Clinical trial Recruiting at 1 site Observational Ages 18 and up

Imaging inflammation in abdominal aortic aneurysm using a PET tracer

Official title: Molecular Imaging of the Underlying Mechanism of Vessel Wall Inflammation Using Positron Emission Tomography (PET/CT)

Run by University of Pennsylvania · NCT07548099 · Data updated 2026-11-12

Researchers are testing whether a new PET tracer, 64Cu-DOTA-ECL1i, can image inflammation in an abdominal aortic aneurysm.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorUniversity of Pennsylvania
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
StatusRecruiting
StartedApril 30, 2026
Main results expectedApril 30, 2028
Study endsApril 30, 2029
Registry record updatedMay 22, 2026
Trial IDNCT07548099 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with an established abdominal aortic aneurysm or age-matched controls without AAA.

Probably not a fit

Patients with conditions preventing PET imaging or with low GFR, pregnancy, allergy to iodinated contrast, or other exclusion criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study uses a novel radiotracer with PET/CT to visualize inflammation in the aorta of adults with abdominal aortic aneurysm. Participants will undergo baseline PET/CT with 64Cu-DOTA-ECL1i and a follow-up scan about 6-8 weeks later to assess consistency of tracer uptake and the effect of clinical changes on imaging. The goal is to understand whether this molecular imaging approach can reflect inflammatory activity linked to aneurysm biology. The study is conducted at Penn Medicine under institutional guidelines and is not designed as a therapeutic intervention.

Why it matters

Potential benefit: If successful, the imaging approach could help identify inflammatory activity in AAAs and improve understanding of aneurysm biology.

How similar studies have gone: Previous research suggests molecular imaging can visualize vascular inflammation, but this specific tracer in AAA is exploratory and not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Participants will be at least 18 years of age
2. Have an established diagnosis of abdominal aortic aneurysm based on standard clinical criteria or are an age matched control with absence of known AAA.
3. Participants must be informed of the investigational nature of this study and be willing to provide written informed consent and participate in this study in accordance with institutional and federal guidelines prior to study-specific procedures.

Exclusion Criteria:

1. Females who are pregnant or breast feeding at the time of the PET/CT scan will not be eligible for this study; a urine pregnancy test will be performed in women of child-bearing potential before the injection of radiotracer.
2. Inability to tolerate imaging procedures in the opinion of an investigator or treating physician
3. Patients with chronic renal disease whose GFR is less than 40 mL/min/1.73m² at the time of enrollment.
4. Documented allergy to iodinated contrast
5. Any current medical condition, illness, or disorder as assessed by medical record review and/or self-reported that is considered by a physician investigator to be a condition that could compromise participant safety or successful participation in the study
6. Less than 6 months life expectancy as deemed by the treating physician at the time of initial enrollment.

Where it's running

  • Penn Medicine; Perelman School of Medicine
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.